Sep 18, 2014
Toray Industries has selected tebu-bio and their laboratories to strengthen Toray’s microarray platform in the European market.
Jul 01, 2014
Stemgent-Asterand (http://www.stemgent.com), an innovative provider of cellular reprogramming reagents and iPS cell reprogramming services, and tebu-bio (http://www.tebu-bio.com) are pleased to announce their new sales and marketing agreement...
Jan 30, 2014
tebu-bio is pleased to announce their agreement with EpiCypher™ to distribute their innovative product range throughout Europe
Jul 22, 2013
Researchers across Europe are now able to access StemCultures' FGF2 through tebu-bio’s pan-European network of offices.
Dec 18, 2012
tebu-bio announces today a distributor agreement with research antibody maker Biosensis bringing innovative tools for Life Sciences to European researchers
Jul 17, 2012
tebu-bio is pleased to announce their recent distribution agreement with CellResearch Corporation Pte Ltd.
Jul 13, 2012
tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.
Jul 03, 2012
tebu-bio is pleased to announce their recent partnership with Smartox Biotechnology
Apr 26, 2012
tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.
Mar 27, 2012
Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.